Tumor environment study in advanced ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at the environment around ovarian cancer tumors to better understand the disease. It might help researchers find new ways to treat patients with advanced ovarian cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a type of ovarian cancer called serous ovarian carcinoma.
- Your cancer is at an advanced stage (stage III or IV).
- You have not taken drugs that weaken your immune system in the last 6 months.
- You do not have a weakened immune system from a condition or treatment.
- You have not had chemotherapy for another cancer in the past year.
- Your body mass index (BMI) is 30 or less.
- You are willing and able to have surgery for your cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses lab-grown tumor models (organoids) from your tissue or fluid sample to find the best treatment for your ovarian cancer.
This study creates miniature 3D versions of endometrial cancer tumors (organoids) from tissue samples taken during surgery. The goal is to better understand the disease and find personalized treatments.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This trial uses a small piece of your cancer tissue (taken during surgery) to grow 'mini-tumors' in the lab. These help doctors find which treatments might work best for you. It is for people with advanced serous ovarian cancer.
This study is looking at how ovarian cancer affects the mesentery (the tissue that holds your intestines in place) in women with advanced ovarian cancer. It helps doctors understand the disease better and may lead to improved treatments.
This study looks at “biomarkers,” meaning measurable signals in blood and tumor tissue, in people with advanced ovarian-type cancers. The goal is to understand these markers and how they relate to the cancer, which may help guide future care.
Hear when a new Ovarian Cancer Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.